Hill staffers do not expect pharma pushback on generic drug laws

The chief minority counsel for the House of Representatives antitrust subcommittee has said he does not expect resistance from brand-name pharmaceutical companies to the legislative effort to increase access to generic versions of drugs.

Get unlimited access to all Global Competition Review content